National Health Investors AI Stock Analysis
National Health Investors (WX6) AI Stock Analysis
National Health Investors
(Frankfurt:WX6)
No summary available
National Health Investors (WX6) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 3.09B
- Dividend Yield
- 5.79%
- Average Volume (3M)
- 235
- Price to Earnings (P/E)
- 4.4
- Beta (1Y)
- 0.05
- Revenue Growth
- 21.66%
- EPS Growth
- 326.52%
- Country
- Germany
- Employees
- 32
- Sector
- Real Estate
- Sector Strength
- 65
- Industry
- REIT - Healthcare Facilities
National Health Investors Business Overview & Revenue Model
Company Description
Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse f...
National Health Investors Earnings Call Summary
The call was broadly positive on NHI's strategic repositioning, investment pipeline, balance sheet, liquidity and long-term SHOP opportunity. However, management acknowledged that third-quarter SHOP performance was below expectations, occupancy growth was slower than anticipated, recurring and unbudgeted CapEx increased, and full-year FAD and NFFO guidance was reduced. The number and significance of the strategic and operating positives outweighed the identified execution challenges.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management expects to recycle more than 95% of the $555 million in NHC sale proceeds before year-end, with approximately $190 million of signed-LOI investments expected to close during the fourth quarter, bringing total 2026 investment to approximately $590 million; it expects 2026 to be its second largest investment year in the company's history, with low to mid-teens unlevered IRRs. The company continues to expect high single-digit to low double-digit organic NOI growth and an objective of high single-digit to low double-digit organic SHOP NOI growth, expects properties acquired before year-end to convert to SHOP in 2027, and expects occupancy to taper as it moves through the holiday season. Revised full year guidance is $4.68 to $4.70 per share for both NAREIT and normalized NFFO and $236.6 million to $237.7 million for funds available for distribution, including approximately $2.3 million in reduced SHOP NOI and increased recurring CapEx of approximately $2.8 million; the company does not expect a special dividend will be required for federal income tax purposes.
National Health Investors Risk Analysis
National Health Investors disclosed 43 risk factors in its most recent earnings report. National Health Investors reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksNational Health Investors Peers Comparison
Overall Rating
OHI83Outperform
CTRE77Outperform
LTC75Outperform
SBRA72Outperform
STRW56Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | $14.32B | 18.60 | 14.32% | 5.74% | 13.90% | 37.56% | |
| 77Outperform | $9.81B | 23.64 | 8.10% | 3.95% | 43.65% | 17.90% | |
| 75Outperform | $2.43B | 4.46 | 39.59% | 5.27% | 68.94% | 1200.88% | |
| 72Outperform | $5.35B | 73.00 | 2.55% | 5.87% | 21.20% | -61.51% | |
| Sector * | 65Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |
| 56Neutral | $691.79M | 55.91 | 25.32% | 5.37% | 10.13% | -63.21% |
* Real Estate Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:WX6 | National Health Investors | 55.50 | -7.25 | -11.55% | |
| LTC | Ltc Properties | 43.28 | 9.29 | 27.31% | |
| OHI | Omega Healthcare Investors | 47.05 | 5.31 | 12.71% | |
| SBRA | Sabra Healthcare Reit | 20.44 | 2.91 | 16.62% | |
| CTRE | CareTrust REIT | 38.07 | 3.12 | 8.92% | |
| STRW | Strawberry Fields REIT Inc | 12.30 | 1.11 | 9.88% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
